Veri Medtech Holdings, which provides a telehealth platform for medical marijuana patients, announced terms for its IPO on Thursday. The company is currently listed on the OTC under the symbol “VRHI”.
The McLean, VA-based company plans to raise $15 million by offering 3.8 million shares at $4.
Veri MedTech offers online and in-person consultations across multiple states. It operates Veriheal, which has completed over 400,000 patient approvals and holds a roughly 5% share of its current market, as well as DosePop, which focuses on direct-to-consumer digital wellness in areas such as weight loss, ADHD, dermatology, anti-aging, and sexual health.
Veri Medtech Holdings was founded in 2017 and booked $11 million in revenue for the 12 months ended December 31, 2025. It plans to list on the Nasdaq under the symbol VRHI. Network 1 Financial Securities is the sole bookrunner on the deal.
